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ORIGINAL

ARTICLE

E n d o c r i n e

C a r e

Height Adjustment in Assessing Dual Energy X-Ray
Absorptiometry Measurements of Bone Mass and
Density in Children
Babette S. Zemel, Mary B. Leonard, Andrea Kelly, Joan M. Lappe,
Vicente Gilsanz, Sharon Oberfield, Soroosh Mahboubi, John A. Shepherd,
Thomas N. Hangartner, Margaret M. Frederick, Karen K. Winer,
and Heidi J. Kalkwarf
Children’s Hospital of Philadelphia (B.S.Z., M.B.L., A.K., S.M.), Philadelphia, Pennsylvania 19104;
Creighton University (J.M.L.), Omaha, Nebraska 68131; Children’s Hospital Los Angeles (V.G.), Los
Angeles, California 90027; Columbia University (S.O.), New York, New York 10032; University of
California at San Francisco (J.A.S.), San Francisco, California 94143; Wright State University (T.N.H.),
Dayton, Ohio 45435; Clinical Trials and Surveys Corp. (M.M.F.), Baltimore, Maryland 21117; National
Institute of Child Health and Human Development (K.K.W.), Bethesda, Maryland 20892; and Cincinnati
Children’s Hospital Medical Center (H.J.K.), Cincinnati, Ohio 45229

Context: In children, bone mineral content (BMC) and bone mineral density (BMD) measurements
by dual-energy x-ray absorptiometry (DXA) are affected by height status. No consensus exists on
how to adjust BMC or BMD (BMC/BMD) measurements for short or tall stature.
Objective: The aim of this study was to compare various methods to adjust BMC/BMD for height
in healthy children.
Design: Data from the Bone Mineral Density in Childhood Study (BMDCS) were used to develop
adjustment methods that were validated using an independent cross-sectional sample of healthy
children from the Reference Data Project (RDP).
Setting: We conducted the study in five clinical centers in the United States.
Participants: We included 1546 BMDCS and 650 RDP participants (7 to 17 yr of age, 50% female).
Intervention: No interventions were used.
Main Outcome Measures: We measured spine and whole body (WB) BMC and BMD Z-scores for age
(BMC/BMDage), height age (BMC/BMDheight age), height (BMCheight), bone mineral apparent density
(BMADage), and height-for-age Z-score (HAZ) (BMC/BMDhaz).
Results: Spine and WB BMC/BMDageZ and BMADageZ were positively (P ⬍ 0.005; r ⫽ 0.11 to 0.64)
associated with HAZ. Spine BMDhaz and BMChazZ were not associated with HAZ; WB BMChazZ was
modestly associated with HAZ (r ⫽ 0.14; P ⫽ 0.0003). All other adjustment methods were negatively
associated with HAZ (P ⬍ 0.005; r ⫽ ⫺0.20 to ⫺0.34). The deviation between adjusted and BMC/
BMDage Z-scores was associated with age for most measures (P ⬍ 0.005) except for BMC/BMDhaz.
Conclusions: Most methods to adjust BMC/BMD Z-scores for height were biased by age and/or HAZ.
Adjustments using HAZ were least biased relative to HAZ and age and can be used to evaluate the
effect of short or tall stature on BMC/BMD Z-scores. (J Clin Endocrinol Metab 95: 1265–1273, 2010)
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Abbreviations: BMAD, Bone mineral apparent density; BMC, bone mineral content; BMD, bone
mineral density; DXA, dual-energy x-ray absorptiometry; HAZ, height-for-age Z-score; WB,
whole body.
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uring childhood and adolescence, body size and maturation are major determinants of bone mineral
content (BMC) and bone mineral density (BMD) as measured by dual-energy x-ray absorptiometry (DXA). As the
skeleton grows and expands, BMC (measured in grams)
increases exponentially. Although DXA measures of areal
BMD (measured in grams per square centimeter) incorporate bone size and are less influenced by body size than
BMC, the bone size adjustment is incomplete. The twodimensional image does not incorporate the depth of
bone; therefore, smaller bones of comparable volumetric
BMD (measured in grams per cubic centimeter) appear to
have lower areal BMD (1). Accordingly, controversy exists regarding the use of areal BMD in children, and BMC
has been proposed as the preferred measure (2– 4).
Like height and weight, the age-related increases in
BMC and BMD are nonlinear, and variability also increases with age. Consequently, pediatric BMD and BMC
results are expressed as Z-scores (SD scores) (5), so that an
individual child’s test results can be appropriately compared with those of his/her same-age peers. However,
many children at-risk for inadequate bone accrual, such as
those with disorders involving inflammation, malabsorption, or immobilization, also have faltering linear growth
and delayed sexual maturation. Consequently, a low
BMD or BMC Z-score in the context of short stature or
delayed maturation is difficult to interpret, raising the
question of the degree to which the low bone status can be
attributed to smaller bone size relative to age.
Recently, the International Society of Clinical Densitometry (ISCD) convened a panel to address the clinical
use of DXA in children, recommending that “in children
with linear growth or maturational delay, spine and total
body (less head) BMC and areal BMD results should be
adjusted for absolute height or height age, or compared
with pediatric reference data that provide age-, sex-, and
height-specific Z-scores” (5). Presently, there are no reference data for determining height-specific Z-scores for
BMC or BMD, nor are there established guidelines on how
to adjust BMC/BMD results for absolute height. A commonly used technique in clinical practice is to substitute
bone age or “height age” (the age at which a child’s height
is the median height-for-age on the growth chart) for chronological age as a means of adjusting for short stature. Of
particular concern with the use of the height age approach
is that children who are short-for-age will be compared
with children of similar height who are younger and at an
earlier stage of sexual maturation. A similar problem may
occur using height-specific Z-scores because they do not
take age into account. Bone mineral apparent density
(BMAD) has also been used as a size-adjusted measure of
DXA BMD (6). An alternative approach that would si-
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multaneously consider both height and age involves adjusting for height-for-age Z-score (HAZ). The appropriateness of these approaches has not been assessed.
Establishing criteria for evaluating the validity of adjustment approaches is a significant challenge. In the absence of
a gold standard for determining bone mineral “status” in
children, the choice of an adjustment technique can be based
on carefully conceived relative criteria. We propose that ideal
size-adjustment techniques will result in similar Z-score distributions among healthy children who are of short, tall, and
average stature. The ideal technique will not exhibit bias with
respect to height (i.e. will have a zero correlation with HAZ)
and age (i.e. will have the same effect at all ages). Comparisons in healthy children are important to identify potential
biases in various techniques to account for short stature in
children with chronic diseases, who may have additional factors affecting their bone accretion.
The goals of this study were: 1) to quantify the magnitude of the effect of height status on DXA BMC/BMD
Z-scores; and 2) to compare adjustments to BMC/BMD
Z-scores based upon height age, height-specific reference
data, BMAD, and HAZ in otherwise healthy children.
Specific attention was given to short-for-age or tall-for-age
subgroups to determine whether adjustment techniques
resulted in bone Z-score distributions similar to those of
children of average stature.

Subjects and Methods
Study populations
The first data source was the Bone Mineral Density in Childhood
Study (BMDCS), described previously (7). Briefly, healthy children
from all major racial and ethnic groups were recruited from July
2002 to November 2003 from five regional clinical centers in the
United States: Children’s Hospital of Los Angeles (Los Angeles,
CA), Cincinnati Children’s Hospital Medical Center (Cincinnati,
OH), Creighton University (Omaha, NE), Children’s Hospital of
Philadelphia (CHOP) (Philadelphia, PA), and Columbia University
(New York, NY). The inclusion and exclusion criteria were used to
select a sample of children in good health with normal physical
development and free of previous or current medical conditions that
might affect bone acquisition. Subjects were evaluated annually; the
data presented here are based on the first three visits.
The second data source was a cross-sectional sample of
healthy children recruited as part of the Reference Data Project
on Skeletal Development (RDP) at CHOP, using entry criteria
similar to BMDCS. DXA scans were obtained on the same
scanner model, but a different device from the one used in the
BMDCS. Thus, these data represent an independent validation
sample to compare various height adjustment methods for spine
and whole body (WB) DXA measurements in healthy children
and explore potential biases.
For both studies, written informed consent was obtained
from the participant’s parent or guardian, and assent was obtained from the participants. Participants 18 yr of age or older
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provided written consent. The protocol was approved by the
Institutional Review Boards of each Clinical Center.

Whole Body Bone Mineral Content (BMC) for Height
Reference Curves for Non-Black Females
3000

Bone densitometry

Growth, maturation, and demographic measures
Height and weight were measured with participants dressed
in lightweight clothing, without shoes. For the BMDCS, pubertal
stage was determined by physical examination performed by a
physician or nurse practitioner with expertise in pediatric endocrinology and categorized using the criteria of Tanner (8). For the
RDP study, Tanner stage was assessed by a validated self-evaluation questionnaire (9, 10).
Ethnicity (Hispanic/Latino vs. Non-Hispanic/Latino) and
race information was elicited by questionnaire using National
Institutes of Health classifications. For these analyses, race was
categorized as Black vs. all other races.

Statistical analysis
Calculation of Z-scores
Sex-specific HAZ, weight-for-age, and body mass index-forage Z-scores were calculated using the Centers for Disease Control and Prevention (CDC) 2000 growth charts (11).
Sex- and race-specific BMC and BMD-for-age Z-scores were
calculated using the BMDCS reference data (7) (BMCageZ
and BMDageZ). In addition, Z-scores were calculated substituting height age for chronological age, thereby generating
BMCheight ageZ and BMDheight ageZ. Height age was determined
as the age at which the child’s height was the median value for
height from the CDC growth chart. Children whose height was
greater than the median value for height in young adults (age 20)
were not assigned a height age.

Creation of additional BMDC reference curves
Additional sex- and race-specific reference curves for spineand WB BMC-for-height (BMCheightZ) and BMAD-for-age
(BMADage) (6) were generated using the same source data and tech-
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For the BMDCS, DXA scans of the WB, posteroanterior lumbar
spine (L1–L4, fast array mode), nondominant forearm, and left
proximal femur (fast array) were obtained using bone densitometers (QDR4500A, QDR4500W, and Delphi A models; Hologic,
Inc., Bedford, MA) as described previously (7). All scans were analyzed centrally by the DXA Core Laboratory (University of California, San Francisco, CA) using Hologic software release 12.3.
For the RDP Study, posteroanterior lumbar spine (array
mode) and WB scans were obtained on a Delphi A model, following the same positioning and analysis techniques. Scans were
analyzed using Hologic software release 12.4 and reviewed by a
single investigator (B.S.Z.) for quality assurance. CHOP maintains two identical DXA models at different locations, one used
for the RDP study and the other used for the BMDCS. Crosscalibration of these DXA devices using WB phantoms and human volunteers revealed differences in WB BMC and BMD measurements. A multiplicative correction factor was applied to the
WB results for the RDP study to rectify the calibration difference.
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FIG. 1. Example of BMC for height reference curves for generating
BMCheight Z-scores. Reference lines from ⫺2 SD to ⫹2 SD from the
median are shown.

niques used to create the BMDCS reference data (7). BMAD was
calculated as BMC/bone area1.5 for the spine and BMC/height for
the WB (6). The curves were created with the LMS method (12)
using the LMS Chartmaker software as illustrated in Fig. 1 (13).
The LMS values resulting from the creation of these curves were
used to calculate Z-scores for BMCheight and BMADage.

HAZ predicted bone Z-score model development and
adjustment for HAZ
The relationships between HAZ and bone Z-scores
(BMCageZ, BMDageZ) for spine, WB, hip, and forearm were
determined by random effects generalized least squares regression. The source data were the same as those used to create the
published BMDCS reference curves described above, accounting
for the multiple observations per subject. Sex and race differences in the relationship between HAZ and bone Z-scores were
complex, so separate analyses were performed for each sex and
for Black vs. non-Black samples. Interaction and higher-order
polynomial terms were evaluated to determine whether they improved the model fit. Residual plots were inspected to confirm
the absence of age trends in the fit of the models.
The resulting models provided prediction equations to calculate HAZ-predicted bone Z-scores. The HAZ-adjusted BMC
or BMD Z-scores (BMChazZ and BMDhazZ) were calculated as:

Equation1a:
BMChazZ ⫽ BMCageZ⫺ HAZ-predicted BMC Z-score
Equation1b:
BMDhazZ ⫽ BMDageZ⫺ HAZ-predicted BMD Z-score
Using this approach, if a subject’s bone Z-score is appropriate
for his/her height status, then the adjusted Z-score is zero. If the bone
Z-score is greater than expected given the height status, the HAZadjusted Z-score is positive, and if the bone Z-score is less than
expected given the height status, then the HAZ-adjusted Z-score is
negative.1
Example: for a 14.6 yr old Caucasian boy with a spine BMDageZ of ⫺2.20 and HAZ of ⫺1.80,
his predicted HAZ-adjusted spine BMD Z would be: (14.6 * ⫺0.016) ⫹ (⫺1.80 * 0.228) ⫹
(14.6*⫺1.80*0.024)⫹0.148⫽⫺1.13.HisspineBMDhazZwouldbe⫺2.20⫺(⫺1.13)⫽⫺1.07.
Therefore, a large portion of his low BMD for age may be attributable to his short stature.

1

1268

Zemel et al.

Height Adjustment for Bone Density in Children

J Clin Endocrinol Metab, March 2010, 95(3):1265–1273

TABLE 1. Descriptive statistics
BMDCS cohort (n ⴝ 1546)
Variable
Age (yr)
Height age (yr)a
Height Z-score
Weight Z-score
BMI Z-score
a

Mean
11.8
11.5
0.2
0.3
0.3

SD

2.7
2.7
0.8
0.8
0.9

Minimum
7.0
5.6
⫺2.6
⫺2.2
⫺2.7

RDP sample (n ⴝ 650)

Maximum
17.0
19.4
2.7
2.4
2.3

Mean
11.4
11.4
0.3
0.4
0.4

SD

2.7
2.8
0.9
1.0
1.0

Minimum
7.0
5.6
⫺2.3
⫺2.3
⫺3.3

Maximum
17.0
19.4
3.2
3.5
3.0

n ⫽ 1420 for the Bone Mineral Density in Childhood Study (BMDCS) cohort and n ⫽ 593 for the Reference Data Project (RDP) sample.

Statistical analyses
The published BMC and BMD reference data are limited to
ages 6 to 16 yr for girls and 6 to 17 yr for boys, so results were
restricted to these age ranges. Descriptive statistics were calculated for the outcome measures for both study samples and/or for
the subgroups described below.
t-Tests were used to determine whether the mean adjusted
Z-scores in the RDP sample were significantly different from
zero. Subjects were divided into short (HAZ ⬍ ⫺1), average
(⫺1 ⱕ HAZ ⱕ 1), and tall (HAZ ⬎ 1) groups. One-way ANOVA
was used to test for significant differences in bone Z-scores across
HAZ groups. The absence of statistically significant differences
between groups was used as one criterion for evaluating adjustment methods because an appropriate adjustment technique
would result in similar Z-score distributions for short, average,
and tall children. Pearson correlations were examined to determine whether Z-score adjustment methods were significantly
associated with HAZ (i.e. not independent of height status).
Bias in adjustment methods was further explored by testing
for age trends, i.e. an unbiased adjustment technique would result in the same pattern of adjustment across all ages. All height
adjustment methods were compared with BMCage and BMDage
Z-scores, respectively, by calculating the difference between the Zscores. For example, the difference between spine BMCheight ageZ
and spine BMCageZ was computed for further analysis. Graphical
inspection, correlation, and regression analyses were used to test
for age trends in these Z-score differences.
All statistical analyses were performed in STATA 10.0 (StataCorp, College Station, TX), and a P value of 0.05 was considered
statistically significant.

Results
Description of the study samples
BMDCS
Of the original 1554 subjects recruited at baseline, 93%
(n ⫽ 1438) returned for the third study visit. However,
because the published reference data for calculating BMC
and BMD-for-age Z-scores does not encompass the entire
age range, the data presented here are restricted to the
3945 observations on 1546 subjects (7 to 16 yr of age for
girls and 7 to 17 yr of age for boys) for whom bone Zscores could be calculated. This subsample was 50% female and 24% Black. Thirty-five percent of the sample
were prepubertal (Tanner stage 1) at the time of the study

visit, 38% were peripubertal (Tanner stages 2 through 4),
and 27% had completed puberty (Tanner stage 5).
RDP study
A total of 850 subjects were recruited. Of these, 650
were in the age range for which the BMDCS bone Z-scores
could be calculated. The subsample was 45% Black and
50% female; 33% were prepubertal (Tanner stage 1),
56% were peripubertal (Tanner stages 2 through 4), and
10% had completed puberty (Tanner stage 5).
Descriptive statistics for each sample are presented in
Table 1. The RDP sample was significantly (P ⬍ 0.05)
younger, taller, and heavier than the BMDCS, but the
magnitude of the differences was small.
Comparison of height adjustment methods
HAZ adjustment of bone Z-scores
Prediction equations for the calculation of HAZ adjusted bone Z-scores using the BMDCS data (Table 2)
demonstrated that the relationship between HAZ and
bone Z-scores was complex. For many measurement sites,
the interaction term for age and HAZ was significant,
signaling that the effect of HAZ on bone Z-score varied as
a function of age. In some cases, a higher-order polynomial
term (age2 and the interaction of age2 and HAZ) improved
the fit of the model. In general, the explained variance
(overall R2) for these models was greater for BMC than for
BMD measures, greater for females than males, and
greater for non-Black than Black children. The effect of
HAZ on hip and forearm outcomes was small, with R2
values ranging from 0.02 to 0.13.
Comparison of bone Z-scores
Bone Z-scores using chronological age, height age,
HAZ adjustment equations, BMADage, and BMCheight
were calculated for the RDP sample. The means (⫾ SD) for
spine BMCageZ and BMDageZ (Table 3) were not significantly different from 0.0 ⫾ 1.0, indicating similar
Z-score distributions for the RDP and BMDCS samples.
WB BMCageZ was significantly greater than zero for the
RDP sample. Of the various height adjustment methods,
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TABLE 2. Prediction equations for BMC and BMD Z-scores based on HAZ
Prediction equation
Spine BMC for age
Males
Non-Black
Black
Females
Non-Black
Black
Spine BMD for age
Males
Non-Black
Black
Females
Non-Black
Black
WB BMC for age
Males
Non-Black
Black
Females
Non-Black
Black
WB BMD for age
Males
Non-Black
Black
Females
Non-Black
Black
Hip neck BMD for age
Males
Non-Black
Black
Females
Non-Black
Black
Total hip BMD for age
Males
Non-Black
Black
Females
Non-Black
Black
Forearm BMD for age
Males
Non-Black
Black
Females
Non-Black
Black

R2

⫺0.013ⴱAge ⫹ 0.833ⴱHAZ ⫹ 0.086
0.035ⴱAge ⫹ 0.213ⴱHAZ ⫹ 0.037ⴱAgeⴱHAZ ⫺ 0.636

0.35
0.30

⫺0.024ⴱAge ⫹ 0.562ⴱHAZ ⫹ 0.019ⴱAgeⴱHAZ ⫹ 0.204
0.419ⴱHAZ ⫺ 0.078

0.37
0.25

⫺0.016ⴱAge ⫹ 0.228ⴱHAZ ⫹ 0.024ⴱAgeⴱHAZ ⫹ 0.148
0.025ⴱAge ⫹ 0.430ⴱHAZ ⫺ 0.438

0.10
0.11

⫺0.032ⴱAge ⫹ 0.325ⴱHAZ ⫹ 0.017ⴱAGEⴱHAZ ⫹ 0.322
0.337ⴱHAZ ⫺ 0.067

0.16
0.05

⫺0.021ⴱAge ⫹ 0.631ⴱHAZ ⫹ 0.013ⴱAgeⴱHAZ ⫹ 0.183
⫺0.187ⴱAge ⫹ 1.497ⴱHAZ ⫹ 0.010ⴱAge2 ⫺ 0.204ⴱAgeⴱHAZ ⫹ 0.010ⴱAge2ⴱHAZ ⫹ 0.646

0.40
0.36

⫺0.027ⴱAge ⫹ 0.572ⴱHAZ ⫹ 0.015ⴱAgeⴱHAZ ⫹ 0.244
⫺0.159ⴱAge ⫹ 1.146ⴱHAZ ⫹ 0.008ⴱAge2 ⫺ 0.149ⴱAgeⴱHAZ ⫹ 0.008ⴱAge2ⴱHAZ ⫹ 0.567

0.44
0.35

⫺0.031ⴱAge ⫹ 0.411ⴱ HAZ ⫹ 0.343
⫺0.028ⴱAge ⫹ 1.193ⴱHAZ ⫹ 0.002ⴱAge2 ⫺ 0.216ⴱAgeⴱHAZ ⫹ 0.011ⴱAge2ⴱHAZ ⫺ 0.067

0.11
0.08

⫺0.052ⴱAge ⫹ 0.533ⴱHAZ ⫹ 0.548
0.225ⴱHAZ ⫺ 0.052

0.17
0.14

⫺0.018ⴱAge ⫹ 0.361ⴱHAZ ⫹ 0.189
0.034ⴱAge ⫹ 0.279ⴱHAZ ⫺ 0.506

0.06
0.05

⫺0.021ⴱAge ⫹ 0.440ⴱHAZ ⫹ 0.202
Not significant

0.12
Ns

⫺0.028ⴱAge ⫹ 0.009ⴱHAZ ⫹ 0.033ⴱAgeⴱHAZ ⫹ 0.292
⫺0.092ⴱAge ⫹ 1.446ⴱHAZ ⫹ 0.005ⴱAge2 ⫺ 0.239ⴱAgeⴱHAZ ⫹ 0.011ⴱAge2ⴱHAZ ⫹ 0.277

0.04
0.04

⫺0.264ⴱAge ⫹ ⫺0.454ⴱHAZ ⫹ ⴱ0.010ⴱAge2 ⫹ 0.150ⴱAgeⴱHAZ ⫺ 0.005ⴱAge2ⴱHAZ ⫹ 1.586
0.022ⴱAge ⫺ 0.290ⴱHAZ ⫹ 0.043ⴱAgeⴱHAZ ⫺ 0.285

0.11
0.02

0.370ⴱHAZ ⫺ 0.028
0.045ⴱAge ⫹ 0.291ⴱHAZ ⫺ 0.636

0.06
0.07

0.462ⴱHAZ ⫺ 0.042
0.031ⴱAge ⫹ 0.308ⴱHAZ ⫺ 0.422

0.13
0.11

Age in years is used in all calculations.

mean spine BMADage and WB BMCheight ageZ were not
significantly different from zero. All others had mean values that differed significantly from the expected values
(Z-score mean of zero).
Unadjusted BMCageZ and BMDageZ were significantly
and positively associated with HAZ (Table 3). That is,
children with lower height relative to age had lower BMC
and BMD relative to age. Spine BMDhaz and BMChazZ were
not significantly associated with HAZ; WB BMChazZ was
modestly associated with HAZ (r ⫽ 0.14). All other ad-

justment methods were significantly and negatively associated with HAZ. Spine and WB BMADageZ were positively associated with HAZ. There were highly significant
differences between short, average, and tall children in
bone Z-scores, with the exception of spine BMChaz and
BMDhazZ (Fig. 2).
Differences between adjusted and unadjusted Z-scores
were significantly (P ⱕ 0.05) correlated with age for most
measures, ranging from r ⫽ ⫺0.07 for WB BMADage to
0.24 for spine and WB BMCheight ageZ. The HAZ adjust-
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with HAZa

Spine BMD Z-Score

Spine BMC
BMCage
BMCheight age
BMCheight
BMChaz
Spine BMD
BMDage
BMDheight age
BMADage
BMDhaz
WB BMC
BMCage
BMCheight age
BMCheight
BMADage
BMChaz

SD

-4

All
Mean

4

TABLE 3. Unadjusted and adjusted BMC and BMD
Z-scores for the RDP cohort
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Discussion
Previous bone mineral acquisition in childhood studies
demonstrated the importance of linear growth and sexual
maturation on bone outcomes (14 –22). However, guidelines for incorporating body size into clinical interpretation of DXA-based bone outcomes have not been established, and there has been limited consideration of how to
validate size-related adjustments of bone outcomes in the
absence of a gold standard for bone health in childhood.
Size-related artifacts in the DXA measures of BMD
have been recognized for some time (4). A widely used
correction for size-related artifacts is BMAD (6, 23). However, BMAD was not specifically designed to address the
growth-related size dependencies. Molgaard et al. (24)
were among the first to propose a scheme for using growth
status in the clinical interpretation of DXA measurements.
They proposed a three-stage approach using height-forage, bone area-for-height, and BMC-for-bone area to correspond to “short” bones, “narrow” bones, and “light”
bones as possible sources of bone deficits. This technique
took advantage of unique sex- and age-specific distribu-
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C
ment method did not result in differences that were significantly associated with age. This was explored further
in children with short and tall stature, as shown in Fig. 3.
Nearly all adjustment methods resulted in a greater change
in Z-score among older children. For the HAZ adjustment
method, the age-related increase was far more modest
than for the other adjustment methods.

BMAD

HAZ-adj

Height Age BMC-for-Ht

p=0.02

FIG. 2. A, Spine BMC Z-scores for age, compared with spine BMC
Z-scores calculated using height age, BMC-for-height, and HAZadjusted Z-score (HAZadj) for short (HAZ ⬍ ⫺1), average (⫺1 ⱕ HAZ ⱕ
1), and tall (HAZ ⬎ 1) children. B, Spine BMD Z-scores for age,
compared with spine BMD Z-scores calculated using height age,
BMAD, and HAZadj for short, average, and tall children. C, WB BMC
Z-scores for age, compared with WB BMC Z-scores calculated using
height age, BMC-for-height, BMAD, and HAZadj for short, average,
and tall children. An unbiased adjustment method will have a similar
Z-score distribution among short, average, and tall children.

tions of height and BMC but did not combine them into a
single measure. The clinical utility of this approach was
never validated. Moreover, with the advent of DXA software and hardware innovations, the source data for this
approach have become obsolete.
Other approaches have since been suggested. Leonard
et al. (3) showed that WB bone area-for-height and BMCfor-height Z-scores were the best indicators of peripheral
quantitative computed tomography measures of bone dimensions and strength; BMC-for-bone area and BMCfor-lean-mass Z-scores were poor indicators of bone
strength. However, they did not evaluate the effects of age
or short or tall stature-for-age. Correction for lean body
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Height for Age Z-score (HAZ) > 1
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FIG. 3. Difference between BMC/BMD for age Z-scores (BMC/BMDage Z-scores) and adjusted Z-scores (e.g. BMC for age ⫺ BMC for height
Z-score) relative to age for short children (A) and tall children (B). An unbiased adjustment method will have a similar effect at all ages.

mass has also been proposed (25, 26) because it correlates
highly with BMC/BMD and is an indicator of the mechanical forces to which bones are exposed. These approaches
require additional assessments (i.e. body composition, puberty stage) and complex calculations, and they do not
offer a validated approach for interpretation of DXA measurements in the context of short (or tall) stature.
The present study evaluated the specific issue of how to
best assess the effect of short (or tall) stature on BMC/
BMD Z-score in clinical practice, with the premise that an
appropriate correction is one that would result in similar
distributions of adjusted BMC or BMD Z-scores among
short, average, and tall children. We used a large independent sample of healthy children free of chronic diseases,
for whom short (or tall) stature is likely to reflect genetic
potential for growth rather than disease processes. This is
a particularly important feature of this validation approach because an appropriate adjustment method should
result in a bias-free distribution of adjusted Z-scores—an
assumption that is not feasible when trying to validate an
adjustment method in samples of children with chronic
disease, where disease severity adversely affects growth
and may get progressively worse with age.
We examined adjustment methods using HAZ, height
age, height-specific reference data, and BMAD in short,
average, and tall children to explore potential biases. The
methods that used height-age and height-specific reference

data yielded Z-scores that were not independent of height
status overall, but among short children the average Zscores were close to zero. However, further inspection revealed that the differences between adjusted and unadjusted Z-scores were age dependent, such that the use of
height age and height-specific reference data had a much
greater effect at older ages than at younger ages, likely due
to the fact that older short children were compared with
younger, less physically mature children. Consequently,
height-age and height-specific reference data inaccurately
represent the effects of short stature on bone outcomes in
older children.
BMAD was adopted to reduce the size-related effects of
DXA areal BMD measurements. However, the analyses
demonstrated that BMAD does not fully remove the effects
of height status on areal BMD. The HAZ adjustment method
was the only approach for which the effects of short (or tall)
stature were not significant and the age effect was most modest. HAZ can easily be calculated using the EpiInfo software
provided to the public at no cost from the Centers for
Disease Control and Prevention (27) and the HAZ adjustment involves simple calculations using the equations provided. Therefore, this technique can be readily applied in
clinical practice, overcoming one of the major obstacles to
applying the ISCD pediatric guidelines.
This study had several limitations. The validation sample consisted mainly of Black and Caucasian children due
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to the study catchment area, and ethnic differences were
not evaluated due to the small sample size that would have
resulted from further subdividing the group of short children by race. In addition, short stature was defined as
HAZ less than ⫺1; there were no children with HAZ less
than ⫺2.0 in the BMDCS at baseline, and none below
⫺2.5 in the validation sample. Some children with chronic
diseases for whom this approach is intended, will have
height deficits that are more severe than the children represented in this sample. Also, the HAZ adjustment is based
on Hologic systems, is not applicable to equipment from
other manufacturers, and does not account for other factors that might influence BMC and BMD such as body
composition.
The strengths of this study far outweigh its limitations.
A large national sample was used to develop the reference
data and various adjustment methods. A large independent sample was used to validate these methods. Several
kinds of comparisons were used to demonstrate that the
HAZ adjustment method most closely met the criteria for
a valid adjustment method. In the peripubertal years, children who have early or delayed puberty are often tall-forage or short-for-age, so in part, the HAZ adjustment
method captures some of the effect of pubertal timing. The
HAZ adjustment technique was not validated for hip and
forearm DXA outcomes, but the analysis showed that
height status had a very modest effect on hip and forearm
Z-scores. The clinical utility of these outcomes remains to
be determined.
In sum, this study demonstrated that DXA bone Zscores adjusted for HAZ yielded the least biased approach
for estimating the effect of short (or tall) stature on measures of BMD. Short children are likely to have lower bone
Z-scores, but the effect of short stature varied as a function
of age. The difference between the unadjusted and HAZadjusted Z-score informs the clinician of the degree to
which a low Z-score may be attributable to short stature,
which may be useful in determining when a child with
decreased BMD requires treatment. Further validation of
this approach using other bone outcomes such as fracture
is needed to fully evaluate the validity of this approach.
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